Octave Specialty Group Inc (OSG)

Purchases of Investments

-$60.30M

TTM · Period ending: · USD

OSG logo

OSG Purchases of Investments

Latest reported-$60.30M
OSG TTM Purchases of Investments (-$521.50M → -$60.30M)
High-resolution chart · PNG

OSG purchases of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Octave Specialty Group Inc Purchases of Investments — Trailing twelve months (TTM) (USD)
Period endingPurchases of Investments (USD)
-60,296,000
-60,663,000
-44,395,000
234,306,000
400,187,000
382,392,000
370,364,000
-198,644,000
-279,636,000
-400,018,000
-495,000,000
-490,000,000
-570,000,000
-513,000,000
-567,000,000
-517,000,000
-427,000,000
-473,000,000
-470,000,000
-564,000,000
-634,000,000
-1,274,000,000
-1,450,000,000
-1,346,479,000
-1,551,796,000
-969,975,000
-1,314,000,000
-1,331,243,000
-1,245,177,000
-1,141,550,000
-541,752,000
-806,794,000
-1,441,956,000
-1,990,201,000
-2,396,458,000
-2,856,536,000
-2,527,121,000
-2,328,352,000
-3,061,857,000
-2,807,243,000
-2,736,378,000
-2,807,251,000
-2,368,714,000
-2,081,866,000
-3,035,315,000
-3,361,006,000
-3,160,656,000
-2,883,646,000
-5,987,064,000
-5,147,472,000
-5,020,362,000
-5,095,091,000
-464,640,000
-847,560,000
-677,327,000
-896,626,000
-1,387,989,000
-1,254,983,000
-1,251,271,000
-1,199,891,000
-1,002,087,000
362,420,000
-1,124,881,000
-1,483,686,000
-2,163,951,000
-3,475,763,000
-2,239,159,000
-1,958,734,000
-1,004,891,000
-1,873,987,000
-3,895,966,000
-4,142,732,000
-6,586,721,000
-6,131,257,000
-4,822,775,000
-4,882,659,000
-3,167,008,000
-4,818,565,000
-4,884,905,000
-5,049,227,000
-5,453,350,000
-5,273,874,000
-5,171,902,000
-6,595,108,000
-6,513,052,000
-5,851,858,000
-5,999,598,000
-5,672,087,000
-6,762,556,000
-6,630,108,000
-7,906,190,000
-9,242,079,000
-8,598,449,000
-9,030,816,000
-7,838,095,000
-8,198,619,000
-7,708,537,000
-7,565,167,000
-7,109,645,000
-4,494,988,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.